Avg closing price
Price range

10 Seth Klarman Theravance Biopharma Inc transactions

Avg closing price
Price range
Increased shares by 37.8% (+3.75 Million shares) Q3 2021
Avg closing price $11.19
Price range $6.77 - $14.41
Increased shares by 13.5% (+1.18 Million shares) Q2 2021
Avg closing price $18.78
Price range $14.52 - $22.46
Sold 6.2% shares (-574 Thousand shares) Q3 2020
Avg closing price $18.73
Price range $14.78 - $22.49
Increased shares by 0.4% (+35.2 Thousand shares) Q3 2017
Avg closing price $32.70
Price range $23.88 - $42.56
Increased shares by 26.2% (+1.92 Million shares) Q4 2016
Avg closing price $31.02
Price range $24.57 - $38.58
Increased shares by 13.1% (+850 Thousand shares) Q2 2016
Avg closing price $21.59
Price range $17.45 - $24.20
Increased shares by 1.3% (+81 Thousand shares) Q1 2016
Avg closing price $16.36
Price range $13.35 - $18.80
Increased shares by 0.8% (+53.5 Thousand shares) Q2 2015
Avg closing price $15.51
Price range $12.57 - $18.63
Increased shares by 5.0% (+305 Thousand shares) Q1 2015
Avg closing price $18.33
Price range $14.70 - $21.73
New holding (+6.06 Million shares) Q2 2014
Avg closing price $30.10
Price range $23.51 - $34.87

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!